Lau EMC, Dinavahi R, Woo YC, Wu CH, et al. Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study. Osteoporos Int 2020 Feb 11. pii: 10.1007/s00198-020-05324.
PMID: 32047951